Capital Impact Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Capital Impact Advisors’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,744	Closed	-$894K	–	105
2024 Q1	$894K	Buy	+2,744	New	+$674K	1.16%	34
2023 Q3	–	Sell	-2,899	Closed	-$827K	–	171
2023 Q2	$827K	Sell	2,899 -1,933	-40%	-$537K	0.91%	25
2023 Q1	$1.05M	Buy	4,832 +151	+3%	+$29.4K	1.29%	3
2022 Q4	$962K	Buy	4,681 +339	+8%	+$85.7K	0.94%	14
2022 Q3	$1.08M	Sell	4,342 -307	-7%	-$78.1K	1.07%	7
2022 Q2	$889K	Sell	4,649 -796	-15%	-$141K	0.82%	14
2022 Q1	$1.13M	Buy	+5,445	New	+$898K	0.82%	21

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Capital Impact Advisors's SWAV Position: Q2 2024 in Review

Capital Impact Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 2,744 shares — an estimated $894K sold.

Capital Impact Advisors first reported a position in SWAV in Q1 2022 and held it in 7 quarters. The position peaked at $1.13M in Q1 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

Capital Impact Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Capital Impact Advisors sold 2,744 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $894K.
Capital Impact Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
Capital Impact Advisors's Shockwave Medical, Inc. Common Stock position peaked at $1.13M in Q1 2022.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Capital Impact Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.